The Lancet Profiles Successful tuberculosis treatment in Ukraine

An new article in The Lancet highlights the successes of treating people with drug-resistant TB with the six-month, all oral treatment regimen available through LIFT-TB. The full article can be found on The Lancet’s website.

More information and personal stories detailing the use of this regimen for treating drug-resistant TB in Ukraine are detailed in the video below.








Previous
Previous

Kyrgyzstan, Ukraine, and Uzbekistan Update National Guidelines for Drug-Resistant TB Treatment to Advance National Rollout of Three-Drug, Six-Month Regimen

Next
Next

Price reduction paves the way for expanded access to highly effective multidrug-resistant tuberculosis treatment